MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
Ozawa N, Yokobori T, Osone K, Bilguun EO, Okami H, Shimoda Y, Shiraishi T, Okada T, Sano A, Sakai M, Sohda M, Miyazaki T, Ide M, Ogawa H, Yao T, Oyama T, Shirabe K, Saeki H.
Ozawa N, et al. Among authors: ide m.
Int J Cancer. 2024 Jan 15;154(2):359-371. doi: 10.1002/ijc.34722. Epub 2023 Sep 7.
Int J Cancer. 2024.
PMID: 37676657